NCT03790215View on ClinicalTrials.gov

Dydrogesterone in the Treatment of Endometrial Polyps

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2019

Conditions
Endometrial Polyp
Interventions
DRUG

Dydrogesterone

The investigators give participants oral dydrogesterone(as described in arm description).After 3 cycles of treatment, the investigators evaluate the treatment effects.

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT03790215 - Dydrogesterone in the Treatment of Endometrial Polyps | Biotech Hunter | Biotech Hunter